Boston (ots/PRNewswire) - For non-US medical media only. For journalistic assessment and preparation before publication. Abstract #689-P Findings from a clinical trial comparing Victoza® (liraglutide 1.8 mg) and sitagliptin (100 mg), both in combination with metformin, demonstrated that switching from sitagliptin ...
Boston (ots/PRNewswire) - For non-US medical media only. For journalistic assessment and preparation before publication. Abstract #OR15-1 Findings from the first phase 3a clinical trial for semaglutide, an investigational glucagon-like peptide-1 (GLP-1) analogue, demonstrated that treatment with semaglutide ...
London And Boston (ots/PRNewswire) - Positive Technologies, a leading provider of security solutions, today announced it has been positioned by Gartner, Inc. in the "Visionaries" quadrant of the Gartner Magic Quadrant for Web Application Firewalls. Positive Technologies is placed the furthest to the right in the Visionaries quadrant based on its completeness of vision. ...
Boston (ots/PRNewswire) - - 166-OR This material is intended for medical non-UK media only. For journalistic assessment and preparation before publication. New phase 3b findings showed adults with type 2 diabetes treated with Xultophy(R) (IDegLira), a once-daily, single-injection combination of insulin degludec and ...
Boston, Massachusetts (ots/PRNewswire) - This material is intended for medical non-UK media only. For journalistic assessment and preparation before publication Abstract #1121-P New findings showed that adults with type 2 diabetes treated with Victoza(R) , in combination with metformin, experienced similar ...
London And Boston (ots/PRNewswire) - The industry is poised for a healthier turn after sales declined in 2012, says Evaluate's "World Preview 2013, Outlook to 2018" report According to the newly-released World Preview report from market intelligence firm Evaluate Ltd, the worst of the patent cliff is behind us. ...
London And Boston (ots/PRNewswire) - EP Vantage(R) [http://www.epvantage.com/default.aspx ], EvaluatePharma(R) [http://www.evaluatepharma.com ]'s award-winning editorial team, today released its "2012 Year in Review [http://www.evaluatepharma.com/epvreview2012 ]" report. Despite numerous ups and downs, the sector exited on a positive note, giving hope that 2013 might be the start of sustained recovery. According to the report, Biotech stocks stormed ahead with the NASDAQ ...
Boston, Massachusetts (ots/PRNewswire) - - Study presented at American Association for the Study of Liver Diseases 2012 shows high sustained virological response (SVR) in HCV/HIV co-infected patients receiving INCIVO(R) (telaprevir)-based regimen - Janssen Infectious Diseases-Diagnostics BVBA (Janssen) today ...
London And Boston (ots/PRNewswire) - - EvaluateMedTech(TM) World Preview 2018 Reveals Medtech Sales Growth Rate Forecast to Outperform Global Prescription Drug Market Between 2011 and 2018 EvaluatePharma [http://www.evaluatepharma.com ](R) the premier source for life science sector analysis and consensus forecasts, today released its EvaluateMedTech(TM) World Preview 2018 [http://www.evaluatemedtech.com/MT2018 ] report at ...
London And Boston (ots/PRNewswire) - EvaluatePharma [http://www.evaluatepharma.com ], the premier source for life science sector analysis and consensus forecasts, today announced the launch of EvaluateMedTech [http://www.evaluatemedtech.com ](TM), a new intelligence service focused on the medical device and diagnostic sector. Powered by EvaluatePharma's proven platform ...
London And Boston (ots/PRNewswire) - EvaluatePharma [http://www.evaluategroup.com ](R), the premier source for life science sector analysis and consensus forecasts, has appointed Alexander Karle as Chief Operating Officer. Karle's experience in formulating customer-centric growth strategies and leading them to successful implementation will be instrumental in driving EvaluatePharma's continued expansion within key ...
Boston (ots/PRNewswire) - EvaluatePharma [http://www.evaluatepharma.com ](R), the premier source for pharmaceutical and biotechnology sector analysis and consensus forecasts, has named Debbie Paul to the position of CEO Americas, EvaluatePharma USA, Inc. effective immediately. In her new role, Paul leads EvaluatePharma's growing North American operations and its ...